✦ LIBER ✦

The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics

✍ Scribed by P. Levin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Similar risk of malignancy with insulin

✍ J. Rosenstock; V. Fonseca; J. B. McGill; M. Riddle; J. P. Hallé; I. Hramiak; P. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 73 KB

Evaluation of exenatide vs. insulin glar

✍ T. Mittendorf; J. Smith-Palmer; L. Timlin; M. Happich; G. Goodall 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

Similar progression of diabetic retinopa

✍ J. Rosenstock; V. Fonseca; J. B. McGill; M. Riddle; J.-P. Hallé; I. Hramiak; P. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 218 KB

Insulin therapy in type 2 diabetes patie

✍ J. A. Ray; W. J. Valentine; S. Roze; L. Nicklasson; D. Cobden; P. Raskin; A. Gar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Comparison of Safety and Efficacy of Ins

✍ Pearl Lee; Annette Chang; Caroline Blaum; Aleksandra Vlajnic; Ling Gao; Jeffrey 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Similar progression of diabetic retinopa

✍ J. Rosenstock; V. Fonseca; J. B. McGill; M. Riddle; J.-P. Hallé; I. Hramiak; P. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 84 KB